201 related articles for article (PubMed ID: 10416916)
1. IV milrinone for cardiac output increase and maintenance: comparison in nonhyperdynamic SIRS/sepsis and congestive heart failure.
Heinz G; Geppert A; Delle Karth G; Reinelt P; Gschwandtner ME; Neunteufl T; Zauner C; Frossard M; Siostrzonek P
Intensive Care Med; 1999 Jun; 25(6):620-4. PubMed ID: 10416916
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study.
Barton P; Garcia J; Kouatli A; Kitchen L; Zorka A; Lindsay C; Lawless S; Giroir B
Chest; 1996 May; 109(5):1302-12. PubMed ID: 8625683
[TBL] [Abstract][Full Text] [Related]
3. Milrinone therapy in catecholamine-dependent critically ill patients with heart failure.
Siostrzonek P; Koreny M; Delle-Karth G; Haumer M; Koller-Strametz J; Heinz G
Acta Anaesthesiol Scand; 2000 Apr; 44(4):403-9. PubMed ID: 10757572
[TBL] [Abstract][Full Text] [Related]
4. The use of milrinone in pre-transplant assessment of patients with congestive heart failure and pulmonary hypertension.
Pamboukian SV; Carere RG; Webb JG; Cook RC; D'yachkova Y; Abel JG; Ignaszewski AP
J Heart Lung Transplant; 1999 Apr; 18(4):367-71. PubMed ID: 10226902
[TBL] [Abstract][Full Text] [Related]
5. Short-term intravenous milrinone for severe congestive heart failure: the good, bad, and not so good.
Varriale P; Ramaprasad S
Pharmacotherapy; 1997; 17(2):371-4. PubMed ID: 9085331
[TBL] [Abstract][Full Text] [Related]
6. Intermittent milrinone effect on long-term hemodynamic profile in patients with severe congestive heart failure.
Hatzizacharias A; Makris T; Krespi P; Triposkiadis F; Voyatzi P; Dalianis N; Kyriakidis M
Am Heart J; 1999 Aug; 138(2 Pt 1):241-6. PubMed ID: 10426834
[TBL] [Abstract][Full Text] [Related]
7. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
[TBL] [Abstract][Full Text] [Related]
8. Assessment of inotropic and vasodilating effects of milrinone lactate in patients with dilated cardiomyopathy and severe heart failure.
Bregagnollo EA; Fortes AH; Cicogna AC
Arq Bras Cardiol; 1999 Feb; 72(2):149-60. PubMed ID: 10488574
[TBL] [Abstract][Full Text] [Related]
9. [Value of the use of milrinone in the treatment of acute crisis in patients with congestive heart failure].
Gun C; Piegas LS; Bianco AC; Freire RB; Ramos RF; Timerman A
Arq Bras Cardiol; 1995 Sep; 65(3):255-8. PubMed ID: 8579514
[TBL] [Abstract][Full Text] [Related]
10. [Response to milrinone treatment in patients with chronic congestive heart failure].
Zeng H; Wen S; Huang D; Liu X; Fang Y
Hua Xi Yi Ke Da Xue Xue Bao; 2000 Jun; 31(2):246-7, 259. PubMed ID: 12515150
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: a multicenter study.
Anderson JL; Baim DS; Fein SA; Goldstein RA; LeJemtel TH; Likoff MJ
J Am Coll Cardiol; 1987 Apr; 9(4):711-22. PubMed ID: 3549837
[TBL] [Abstract][Full Text] [Related]
12. Low-dose β-blocker in combination with milrinone safely improves cardiac function and eliminates pulsus alternans in patients with acute decompensated heart failure.
Kobayashi S; Susa T; Tanaka T; Murakami W; Fukuta S; Okuda S; Doi M; Wada Y; Nao T; Yamada J; Okamura T; Yano M; Matsuzaki M
Circ J; 2012; 76(7):1646-53. PubMed ID: 22481100
[TBL] [Abstract][Full Text] [Related]
13. Preload-dependent hemodynamic effects of milrinone in moderate heart failure.
Remme WJ; van Hoogenhuyze DC; Kruijssen HA; Pieper PG; Bruggeling WA
Cardiology; 1992; 80(2):132-42. PubMed ID: 1611632
[TBL] [Abstract][Full Text] [Related]
14. Addition of a β1-Blocker to Milrinone Treatment Improves Cardiac Function in Patients with Acute Heart Failure and Rapid Atrial Fibrillation.
Kobayashi S; Myoren T; Kajii T; Kohno M; Nanno T; Ishiguchi H; Nishimura S; Fukuda M; Hino A; Fujimura T; Ono M; Uchinoumi H; Tateishi H; Mochizuki M; Oda T; Okuda S; Yoshiga Y; Kawano R; Yano M
Cardiology; 2019; 142(4):195-202. PubMed ID: 31137022
[TBL] [Abstract][Full Text] [Related]
15. Comparing the effects of milrinone and olprinone in patients with congestive heart failure.
Dobashi S; Watanabe I; Nakanishi R; Hisatake S; Kiuchi S; Kabuki T; Oka T; Fujii T; Ikeda T
Heart Vessels; 2020 Jun; 35(6):776-785. PubMed ID: 31865433
[TBL] [Abstract][Full Text] [Related]
16. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.
Cuffe MS; Califf RM; Adams KF; Benza R; Bourge R; Colucci WS; Massie BM; O'Connor CM; Pina I; Quigg R; Silver MA; Gheorghiade M;
JAMA; 2002 Mar; 287(12):1541-7. PubMed ID: 11911756
[TBL] [Abstract][Full Text] [Related]
17. Milrinone in congestive heart failure: acute and chronic hemodynamic and clinical evaluation.
Simonton CA; Chatterjee K; Cody RJ; Kubo SH; Leonard D; Daly P; Rutman H
J Am Coll Cardiol; 1985 Aug; 6(2):453-9. PubMed ID: 4019930
[TBL] [Abstract][Full Text] [Related]
18. Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery.
Chang AC; Atz AM; Wernovsky G; Burke RP; Wessel DL
Crit Care Med; 1995 Nov; 23(11):1907-14. PubMed ID: 7587268
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure.
Baim DS; McDowell AV; Cherniles J; Monrad ES; Parker JA; Edelson J; Braunwald E; Grossman W
N Engl J Med; 1983 Sep; 309(13):748-56. PubMed ID: 6888453
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic effects of milrinone with and without a bolus loading infusion.
Baruch L; Patacsil P; Hameed A; Pina I; Loh E
Am Heart J; 2001 Feb; 141(2):266-73. PubMed ID: 11174341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
